Secondary prevention after stroke/transient ischemic attack, a randomized audit&feedback trial
Acta Neurologica Scandinavica Apr 27, 2019
Geary L, et al. - Via conducting a randomized audit&feedback trial, researchers sought to improve the use of secondary preventive stroke drugs and diagnosis recording in ischemic stroke/TIA. In the 18 months following the intervention, medication dispensation for statins, antihypertensives, antiplatelets and anticoagulants, as well as recording of diagnosis, was compared between intervention centers and control centers. There were no differences in the dispensation of medication between intervention and control centers after the intervention, even after adjustment for potential confounders. A simple audit&feedback intervention aimed at primary care doctors did not improve the dispensation of medication to patients with ischemic stroke/TIA 18 months later. Any future audit&feedback intervention aimed at enhancing adherence to guidelines for secondary prevention in primary care should take into account multiple and continuous reminders, the graphic appeal, and expanding recipients to include patients.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries